Oncovac Injection 40mg/ 1ml
Bacillus Calmette-Guerin strain
Oncovac Injection 40mg is used to treat early-stage bladder cancer. It kills cancer cells and lowers the risk of cancer recurrence effectively and safely.
- Strengths 40 mg/ 1 ml
- Form Injection
- Packaging Size 40 mg X 1 Vial
- Packaging Type Box
- Manufacturer Cipla Ltd.
Description of Oncovac Injection 40mg/ 1ml
Oncovac Injection 40mg, also referred to as oncovac inj, is a vaccine-based therapy used to treat early-stage bladder cancer that hasn’t spread to the bladder muscle. It contains BCG (Bacillus Calmette–Guérin), which activates the immune system to attack and destroy cancer cells lining the bladder. This treatment helps reduce the risk of the cancer recurring and is typically administered directly into the bladder (intravesically) under medical supervision. Oncovac Injection is considered a safe and effective approach for non-invasive bladder cancer when used as per the recommended treatment schedule by your healthcare provider.
Ingredients of Oncovac Injection 40mg/ 1ml
- Bacillus Calmette–Guérin (BCG) – 40mg (Active Ingredient)
- Sodium Glutamate and other stabilizers (Inactive Ingredients)
Usage of Oncovac Injection 40mg/ 1ml
- Administered intravesically (directly into the bladder).
- Typically given once a week for several weeks as per schedule.
- Not for intravenous or intramuscular use.
- Administered only by a healthcare professional.
- Follow all instructions regarding fluid intake and urination timing post-injection.
Precautions for Oncovac Injection 40mg/ 1ml
- Avoid use in patients with weak immune systems or active infections.
- Inform your doctor about current medications or past tuberculosis history.
- May cause mild bladder irritation, fever, or flu-like symptoms.
- Drink plenty of fluids post-treatment to flush the bladder.
- Not recommended during pregnancy unless deemed essential.
More like this
Find related medicines from trusted suppliers. Explore similar products to ensure you get the right medication for your needs.
